What Researchers Did
Researchers conducted a 10-month, single-centre study to evaluate the effectiveness of a viable intact cryopreserved human placental membrane (Grafix) for treating complex wounds in 12 patients.
What They Found
All 12 patients achieved complete wound re-epithelialisation and granulation over exposed structures. The mean 4-week wound area reduction was 62.5%, with an average closure time of 10 weeks using 8.1 grafts.
What This Means for Canadian Patients
This treatment could offer a non-surgical alternative for Canadian patients with complex wounds, potentially reducing the need for more invasive procedures. It may also improve patient mobility and rehabilitation by allowing outpatient treatment without donor site morbidity.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's small sample size (n=12) and single-centre design limit the generalizability of its findings.